Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTP synthase 2 is an enzyme encoded by the *CTPS2* gene and is the **rate-limiting enzyme for the synthesis of cytidine triphosphate (CTP) from uridine triphosphate (UTP)**, catalyzing an ATP-dependent amidation using glutamine or ammonia as nitrogen source[1][2][3]. This step is critical for the de novo synthesis of cytosine nucleotides, central to **DNA and RNA synthesis** and general cellular metabolism. CTPS2 activity is tightly regulated allosterically and can form dynamic intracellular filaments associated with changes in metabolic state[5]. Increased CTPS2 activity is observed in proliferating cancer cells, making it a potential target for selective anticancer chemotherapy[1][3]. Loss of CTPS2 function is lethal in certain developmental contexts, consistent with its essential role in nucleotide biogenesis[6].
Inhibition of CTP synthesis (starving cells of cytidine triphosphate necessary for RNA and DNA synthesis); Feedback inhibition by CTP (end-product inhibits its own synthesis[5])
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTP synthase 2 (CTPS2).